Cancer

RSS

New approach to oncolytic, skin disorders based on specific inhibition of 4-hydroxylase

Oct. 2, 2000

Sigma-Tau selects new camptothecin derivative for preclinical development

Oct. 2, 2000

Northwest's prostate cancer vaccine shows favorable progress in clinical trial

Oct. 2, 2000

3-D researchers patent alphav integrin inhibitors with broad indications

Sep. 29, 2000

Two-antigen combination melanoma vaccine enters phase I/II at MGH

Sep. 29, 2000

Results of marimastat/carboplatin combination trial in ovarian cancer disappointing

Sep. 29, 2000

New prostate cancer vaccine selected for clinical trials by Progenics, Cytogen

Sep. 29, 2000

Stable and safe antineoplastic agents developed at Ohio State University

Sep. 28, 2000

Series of cdk inhibitors described in Pharmacia patent

Sep. 28, 2000

Encouraging antitumor activity reported for IGT Pharma's AVLB

Sep. 28, 2000